These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31015906)

  • 1. 2,2-Dimethyl-3,4-dihydro-2
    Pirotte B; Florence X; Goffin E; Lebrun P
    Medchemcomm; 2019 Mar; 10(3):431-438. PubMed ID: 31015906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-Phenylureido/thioureido-substituted 2,2-dimethylchroman analogs of cromakalim bearing a bulky 'carbamate' moiety at the 6-position as potent inhibitors of glucose-sensitive insulin secretion.
    Pirotte B; Florence X; Goffin E; Medeiros MB; de Tullio P; Lebrun P
    Eur J Med Chem; 2016 Oct; 121():338-351. PubMed ID: 27267004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research Advancements on Fluorinated and Non-Fluorinated 4- Phenyl(thio)ureido-Substituted 2,2-Dimethylchromans Acting as Inhibitors of Insulin Release and Smooth Muscle Relaxants.
    Pirotte B; Florence X; Goffin E; Leleux F; Lebrun P
    Med Chem; 2022; 18(8):884-894. PubMed ID: 35189799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deciphering Structure-Activity Relationships in a Series of 2,2-Dimethylchromans Acting as Inhibitors of Insulin Release and Smooth Muscle Relaxants.
    Pirotte B; Florence X; Goffin E; Lebrun P
    ChemMedChem; 2017 Nov; 12(21):1810-1817. PubMed ID: 28967705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the alkylsulfonylamino substituent located at the 6-position of 2,2-dimethylchromans structurally related to cromakalim: from potassium channel openers to calcium entry blockers?
    Florence X; Desvaux V; Goffin E; de Tullio P; Pirotte B; Lebrun P
    Eur J Med Chem; 2014 Jun; 80():36-46. PubMed ID: 24763361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4,6-Disubstituted 2,2-dimethylchromans structurally related to the K(ATP) channel opener cromakalim: design, synthesis, and effect on insulin release and vascular tone.
    Sebille S; de Tullio P; Becker B; Antoine MH; Boverie S; Pirotte B; Lebrun P
    J Med Chem; 2005 Jan; 48(2):614-21. PubMed ID: 15658874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of depolarization on vasorelaxant potency and efficacy of Ca2+ entry blockers, K+ channel openers, nitrate derivatives, salbutamol and papaverine in rat aortic rings.
    Magnon M; Calderone V; Floch A; Cavero I
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Oct; 358(4):452-63. PubMed ID: 9826068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and pharmacological evaluation of R/S-3,4-dihydro-2,2-dimethyl- 6-halo-4-(phenylaminocarbonylamino)-2H-1-benzopyrans: toward tissue-selective pancreatic beta-cell KATP channel openers structurally related to (+/-)-cromakalim.
    Sebille S; Gall D; de Tullio P; Florence X; Lebrun P; Pirotte B
    J Med Chem; 2006 Jul; 49(15):4690-7. PubMed ID: 16854075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural nucleotide analogs are potent activators/inhibitors of pancreatic β cell KATP channels: an emerging mechanism supporting their use as antidiabetic drugs.
    Tricarico D; Rolland JF; Cannone G; Mele A; Cippone V; Laghezza A; Carbonara G; Fracchiolla G; Tortorella P; Loiodice F; Conte Camerino D
    J Pharmacol Exp Ther; 2012 Feb; 340(2):266-76. PubMed ID: 22028392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of new potassium channel activators derived from the ring opening of diazoxide: study of their vasodilatory effect, stimulation of elastin synthesis and inhibitory effect on insulin release.
    Bouider N; Fhayli W; Ghandour Z; Boyer M; Harrouche K; Florence X; Pirotte B; Lebrun P; Faury G; Khelili S
    Bioorg Med Chem; 2015 Apr; 23(8):1735-46. PubMed ID: 25773016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New R/S-3,4-dihydro-2,2-dimethyl-6-halo-4-(phenylaminothiocarbonylamino)-2H-1-benzopyrans structurally related to (+/-)-cromakalim as tissue-selective pancreatic beta-cell K(ATP) channel openers.
    Sebille S; de Tullio P; Florence X; Becker B; Antoine MH; Michaux C; Wouters J; Pirotte B; Lebrun P
    Bioorg Med Chem; 2008 May; 16(10):5704-19. PubMed ID: 18406154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-Alkylamino-4H-pyrido[2,3-e]-1,2,4-thiadiazine 1,1-dioxides structurally related to diazoxide and pinacidil as potassium channel openers acting on vascular smooth muscle cells: design, synthesis, and pharmacological evaluation.
    Pirotte B; Ouedraogo R; de Tullio P; Khelili S; Somers F; Boverie S; Dupont L; Fontaine J; Damas J; Lebrun P
    J Med Chem; 2000 Apr; 43(8):1456-66. PubMed ID: 10780901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological studies of triazolo-/thiadiazolo-benzoxazines.
    Dabholkar VV; Gavande RP
    Acta Pol Pharm; 2012; 69(2):247-52. PubMed ID: 22568038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, characterization and biological evaluation of benzothiazoles and tetrahydrobenzothiazoles bearing urea or thiourea moieties as vasorelaxants and inhibitors of the insulin releasing process.
    Harrouche K; Renard JF; Bouider N; de Tullio P; Goffin E; Lebrun P; Faury G; Pirotte B; Khelili S
    Eur J Med Chem; 2016 Jun; 115():352-60. PubMed ID: 27031211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-alkyl-3-Alkylamino-2H-Benzo- and pyridothiadiazine 1,1-dioxides: from K+ATP channel openers to Ca++ channel blockers?
    Ouedraogo R; Becker B; Boverie S; Somers F; Antoine MH; Pirotte B; Lebrun P; de Tullio P
    Biol Chem; 2002 Nov; 383(11):1759-68. PubMed ID: 12530541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. K-channel opening activity of dihydropyridine ZM244085: effect on 86Rb efflux and 3H-P1075 binding in urinary bladder smooth muscle.
    Trivedi S; Potter-Lee L; McConville MW; Li JH; Ohnmacht CJ; Trainor DA; Kau ST
    Res Commun Mol Pathol Pharmacol; 1995 May; 88(2):137-51. PubMed ID: 7670846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New R/S-3,4-dihydro-2,2-dimethyl-2H-1-benzopyrans as K(ATP) channel openers: modulation of the 4-position.
    Florence X; Sebille S; Tullio Pd; Lebrun P; Pirotte B
    Bioorg Med Chem; 2009 Nov; 17(22):7723-31. PubMed ID: 19822435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular determinants for the activating/blocking actions of the 2H-1,4-benzoxazine derivatives, a class of potassium channel modulators targeting the skeletal muscle KATP channels.
    Tricarico D; Mele A; Camerino GM; Laghezza A; Carbonara G; Fracchiolla G; Tortorella P; Loiodice F; Camerino DC
    Mol Pharmacol; 2008 Jul; 74(1):50-8. PubMed ID: 18403717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and Vasorelaxant Effect of 9-aryl-1,8-acridinediones asPotassium Channel Openers in Isolated Rat Aorta.
    Imenshahidi M; Hadizadeh F; Firoozeh-Moghadam A; Seifi M; Shirinbak A; Gharedaghi MB
    Iran J Pharm Res; 2012; 11(1):229-33. PubMed ID: 24250444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,4,2-Benzo/pyridodithiazine 1,1-dioxides structurally related to the ATP-sensitive potassium channel openers 1,2,4-Benzo/pyridothiadiazine 1,1-dioxides exert a myorelaxant activity linked to a distinct mechanism of action.
    Pirotte B; de Tullio P; Florence X; Goffin E; Somers F; Boverie S; Lebrun P
    J Med Chem; 2013 Apr; 56(8):3247-56. PubMed ID: 23517501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.